Misfeldt Dayton 4
4 · SUNESIS PHARMACEUTICALS INC · Filed Jan 2, 2018
Insider Transaction Report
Form 4
Misfeldt Dayton
Director10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2017-12-29+200,000→ 200,000 totalExercise: $3.69Exp: 2027-12-29→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]The option vests monthly over six (6) months in equal installments subject to optionee's continued service to the Company.